You are here: Industry Insights > Zika vaccine

News List

Enesi Pharma partners with Adelaide University for Zika vaccine pharmaceutical-technology
September 04, 2020
UK-based biotechnology firm Enesi Pharma has partnered with the University of Adelaide in Australia to develop a new vaccine against the Zika virus.
Moderna Receives FDA Fast Track Designation for Zika Vaccine biospectrumasia
August 21, 2019
Investigational Zika vaccine (mRNA-1893) is currently being evaluated in a Phase 1 study for the prevention of Zika virus infection in healthy adults
Zika vaccine shows potential for brain cancer treatment pharmaceutical-technology
September 21, 2018
Researchers at the University of Texas Medical Branch at Galveston (UTMB) in the US have used a Zika vaccine, currently in the development phase, to treat a deadly brain cancer called glioblastoma.
Scientists weigh Zika vaccine challenge study after case count plummets: report fiercepharma
September 21, 2018
Zika captured the world's attention when microcephaly cases started popping up in Brazil back in 2015, and in a fast response, governments and industry quickly committed resources for vaccine research. But after the National Institute for Allergy and Infe
Zika vaccine candidate granted FDA fast track designation europeanpharmaceuticalreview
January 31, 2018
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate…
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract fiercepharma
September 05, 2017
Sanofi didn't know it would be walking into a firestorm when it teamed up with the U.S. Army to develop a Zika vaccine.
Amid dustup over taxpayer-funded research, Sanofi executive says it never rejected a Zika vaccine fa fiercepharma
July 17, 2017
After taking a beating in countless press reports over its Zika vaccine partnership with the U.S. Army, Sanofi is hoping to clear the air. In a series of letters to a U.S. Army official and U.S. senators, executives said Sanofi never rejected a fair prici
Sanofi executive lays out case for taxpayer funding—and exclusive licensing—on Zika vaccine R&D fiercepharma
May 27, 2017
Sanofi has been publicly chastised by lawmakers and public health groups for its proposed Zika vaccine deal with the U.S. Army. Now, an executive is explaining the rationale behind the company’s development plan and defending against claims his company is
U.S. Army can't add a pricing safeguard to Sanofi's Zika vaccine license, official says americanpharmaceuticalreview
April 26, 2017
A U.S. Army official responded to concerns from nonprofit KEI about the government's proposed Zika vaccine license transfer to Sanofi.
Sanofi exec fires back amid fight over Zika vaccine license fiercepharma
March 23, 2017
After taking a beating over a proposed Zika vaccine license from the U.S. Army, Sanofi is hitting back.

Previous page 1 2 Next page